After introducing Expressive Captions in December, the Live Caption panel on Pixel devices now offers a Background ...

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...

The approval of Libtayo (cemiplimab) in advanced NSCLC is for first-line treatment of patients with 50% or more PD-L1 expression and no EGFR, ALK or ROS1 aberrations, taking the drug into a large ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo ® (cemiplimab ... expressing PD-L1 (in ≥ 50% tumour cells), with no EGFR, ALK or ROS1 aberrations ...

There's no shortage of cancer immunotherapies trying ... Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months ...

If your PC can't upgrade to Windows 11, switching to Linux can extend its life past 2025. WattOS is one of the best options I ...

Android 15 made a major change to the way apps work, requiring them to use an "edge-to-edge" format where content from the ...

Commissions do not affect our editors' opinions or evaluations. The best no-fee checking account is Axos Bank Rewards Checking, which scored 4.8 stars (out of a possible 5) thanks to its ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair. A new artificial intelligence (AI) model designed to ...